Natamycin, also marketed under the brand name Natacyn, is a natural antifungal agent produced by the bacterium Streptomyces natalensis. This white powder is widely used in the food industry, medicine, and other sectors due to its ability to inhibit fungal growth without affecting bacteria. In the food industry, it acts as a natural preservative, commonly found in products like yogurt, cheese, dry sausages, and raw ham. In the medical field, it is used topically to treat fungal infections in the eyes and other parts of the body.
The versatility of Natamycin as a safe and effective preservative and antifungal agent has made it a critical component in food preservation and pharmaceutical applications. It is preferred over synthetic alternatives due to its natural origins and low toxicity, especially for human consumption and use.
Market Size
As of 2024, the global Natamycin market was valued at approximately USD 186 million. It is projected to grow at a compound annual growth rate (CAGR) of 6.40%, reaching a total market value of USD 325.08 million by 2032.
This growth is largely driven by the increasing demand for natural preservatives in the food industry and the rising prevalence of fungal infections globally.
In the North American market, Natamycin was valued at USD 53.93 million in 2024, with a growth rate of 5.49% CAGR expected from 2025 through 2032.
The rising consumer demand for clean-label, natural preservatives in food and beverages is expected to significantly boost the market in North America. Furthermore, the growing adoption of Natamycin in medical applications, particularly for treating fungal eye infections, adds to the market's value.
The Natamycin market has seen steady expansion due to the increasing focus on natural ingredients in food and beverage products, particularly in regions such as Europe and Asia-Pacific, where consumer preferences are shifting toward health-conscious and preservative-free products.
Market Dynamics
Drivers
Several factors are driving the growth of the Natamycin market:
-
Growing Consumer Demand for Natural Preservatives: With an increasing consumer preference for organic and clean-label foods, the demand for natural preservatives like Natamycin has risen. Unlike synthetic preservatives, Natamycin is safe, effective, and free from harmful chemicals, making it ideal for modern food production.
-
Rising Fungal Infections Globally: As the incidence of fungal infections grows, especially in regions with high humidity and warmer climates, the demand for antifungal treatments, including Natamycin, continues to rise. This is particularly relevant for skin and eye infections.
-
Stringent Regulations on Chemical Preservatives: Governments worldwide are tightening regulations on synthetic chemicals used in food products. This is accelerating the adoption of natural alternatives such as Natamycin, which complies with food safety standards and regulations in most countries.
Restraints
Despite the growth potential, there are certain barriers to the expansion of the Natamycin market:
-
High Production Costs: The production of Natamycin involves complex fermentation processes, making it relatively more expensive compared to synthetic preservatives. This can limit its widespread use in cost-sensitive industries, particularly in developing regions.
-
Limited Awareness in Certain Regions: In some parts of the world, especially in developing countries, there is still limited awareness of the benefits of Natamycin, which could hinder its market penetration.
Opportunities
The Natamycin market is poised to benefit from several emerging opportunities:
-
Expansion of the Food & Beverage Industry: As the global food and beverage market continues to expand, particularly in emerging economies, the demand for natural preservatives is likely to increase. This presents a growth opportunity for Natamycin producers.
-
Growing Medical Applications: With the rise in the prevalence of fungal infections, particularly in immunocompromised individuals, there is a significant opportunity for Natamycin in pharmaceutical applications. Its use in ophthalmology, particularly for eye infections, represents a growing sector.
Challenges
-
Competition from Synthetic Preservatives: Synthetic preservatives like sodium benzoate and potassium sorbate are still dominant in the market due to their lower cost and long shelf life. Overcoming the price advantage of these alternatives presents a challenge for Natamycin manufacturers.
-
Environmental Concerns in Production: The fermentation process required to produce Natamycin can have an environmental impact, which may draw scrutiny from environmental activists and regulatory bodies focused on sustainable production practices.
Regional Analysis
North America
The North American Natamycin market, particularly in the United States, is expected to witness steady growth due to rising consumer preference for natural and organic ingredients in food. The medical application segment is also anticipated to grow, driven by the increasing prevalence of fungal infections. Furthermore, regulatory bodies like the FDA continue to approve Natamycin for use in food and pharmaceuticals, adding to its market expansion.
Europe
Europe is one of the leading markets for Natamycin due to the stringent regulations on food safety and the growing demand for clean-label products. Countries like Germany, France, and the UK have shown increasing acceptance of natural preservatives, driving the demand for Natamycin in food production. The medical sector is also a key market, with rising cases of eye infections and the growing use of Natamycin as an antifungal agent.
Asia-Pacific
The Asia-Pacific region is expected to exhibit the highest growth during the forecast period. This growth is attributed to the increasing awareness of fungal infections, the rising use of natural food preservatives, and the expanding food processing industry. Countries like China, Japan, and India are seeing significant growth in both food and medical applications of Natamycin.
South America and MEA
In South America and the Middle East and Africa (MEA), the adoption of Natamycin is at an early stage, but the increasing demand for healthier, preservative-free foods provides a substantial opportunity for market penetration. As healthcare access improves, the medical use of Natamycin for treating fungal infections is likely to expand in these regions.
Competitor Analysis
Key Companies
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
These key players dominate the Natamycin market with their robust product portfolios, strategic market positioning, and global distribution networks. Their focus on expanding applications in food preservation and pharmaceutical use is driving the industry forward. These companies are also investing in R&D to improve production efficiency and reduce costs, which could provide a competitive edge in the market.
Global Natamycin Market: Market Segmentation Analysis
This report provides a deep insight into the global Natamycin market, covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and assessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Natamycin. This report introduces in detail the market share, market performance, product situation, operation situation, etc., of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Natamycin market in any manner.
Market Segmentation (by Application)
Market Segmentation (by Type)
- Glucose-based
- Lactose-based
- Sodium chloride-based
Key Company
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
FAQ Section
What is the current market size of the Natamycin market?
- As of 2024, the global Natamycin market size was estimated at USD 186 million and is projected to reach USD 325.08 million by 2032.
Which are the key companies operating in the Natamycin market?
- Key companies in the Natamycin market include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, and others.
What are the key growth drivers in the Natamycin market?
- Key growth drivers include the increasing consumer demand for natural preservatives, rising incidences of fungal infections, and growing regulations on synthetic preservatives.
Which regions dominate the Natamycin market?
- North America, Europe, and Asia-Pacific are the leading regions for the Natamycin market, with the highest growth expected in Asia-Pacific due to expanding food industries and rising medical applications.
What are the emerging trends in the Natamycin market?
- Emerging trends include increased demand for natural preservatives, growing medical applications, and innovations in production processes to reduce costs and environmental impact.
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Natamycin Market
- Overview of the regional outlook of the Natamycin Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natamycin
1.2 Key Market Segments
1.2.1 Natamycin Segment by Type
1.2.2 Natamycin Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Natamycin Market Overview
2.1 Global Market Overview
2.1.1 Global Natamycin Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Natamycin Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Natamycin Market Competitive Landscape
3.1 Global Natamycin Sales by Manufacturers (2019-2025)
3.2 Global Natamycin Revenue Market Share by Manufacturers (2019-2025)
3.3 Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Natamycin Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Natamycin Sales Sites, Area Served, Product Type
3.6 Natamycin Market Competitive Situation and Trends
3.6.1 Natamycin Market Concentration Rate
3.6.2 Global 5 and 10 Largest Natamycin Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Natamycin Industry Chain Analysis
4.1 Natamycin Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Natamycin Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Natamycin Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Natamycin Sales Market Share by Type (2019-2025)
6.3 Global Natamycin Market Size Market Share by Type (2019-2025)
6.4 Global Natamycin Price by Type (2019-2025)
7 Natamycin Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Natamycin Market Sales by Application (2019-2025)
7.3 Global Natamycin Market Size (M USD) by Application (2019-2025)
7.4 Global Natamycin Sales Growth Rate by Application (2019-2025)
8 Natamycin Market Consumption by Region
8.1 Global Natamycin Sales by Region
8.1.1 Global Natamycin Sales by Region
8.1.2 Global Natamycin Sales Market Share by Region
8.2 North America
8.2.1 North America Natamycin Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Natamycin Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Natamycin Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Natamycin Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Natamycin Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Natamycin Market Production by Region
9.1 Global Production of Natamycin by Region (2019-2025)
9.2 Global Natamycin Revenue Market Share by Region (2019-2025)
9.3 Global Natamycin Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Natamycin Production
9.4.1 North America Natamycin Production Growth Rate (2019-2025)
9.4.2 North America Natamycin Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Natamycin Production
9.5.1 Europe Natamycin Production Growth Rate (2019-2025)
9.5.2 Europe Natamycin Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Natamycin Production (2019-2025)
9.6.1 Japan Natamycin Production Growth Rate (2019-2025)
9.6.2 Japan Natamycin Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Natamycin Production (2019-2025)
9.7.1 China Natamycin Production Growth Rate (2019-2025)
9.7.2 China Natamycin Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Danisco
10.1.1 Danisco Natamycin Basic Information
10.1.2 Danisco Natamycin Product Overview
10.1.3 Danisco Natamycin Product Market Performance
10.1.4 Danisco Business Overview
10.1.5 Danisco Natamycin SWOT Analysis
10.1.6 Danisco Recent Developments
10.2 DSM
10.2.1 DSM Natamycin Basic Information
10.2.2 DSM Natamycin Product Overview
10.2.3 DSM Natamycin Product Market Performance
10.2.4 DSM Business Overview
10.2.5 DSM Natamycin SWOT Analysis
10.2.6 DSM Recent Developments
10.3 VGP
10.3.1 VGP Natamycin Basic Information
10.3.2 VGP Natamycin Product Overview
10.3.3 VGP Natamycin Product Market Performance
10.3.4 VGP Natamycin SWOT Analysis
10.3.5 VGP Business Overview
10.3.6 VGP Recent Developments
10.4 Handary
10.4.1 Handary Natamycin Basic Information
10.4.2 Handary Natamycin Product Overview
10.4.3 Handary Natamycin Product Market Performance
10.4.4 Handary Business Overview
10.4.5 Handary Recent Developments
10.5 AMTECH BIOTECH
10.5.1 AMTECH BIOTECH Natamycin Basic Information
10.5.2 AMTECH BIOTECH Natamycin Product Overview
10.5.3 AMTECH BIOTECH Natamycin Product Market Performance
10.5.4 AMTECH BIOTECH Business Overview
10.5.5 AMTECH BIOTECH Recent Developments
10.6 Silver-Elephant
10.6.1 Silver-Elephant Natamycin Basic Information
10.6.2 Silver-Elephant Natamycin Product Overview
10.6.3 Silver-Elephant Natamycin Product Market Performance
10.6.4 Silver-Elephant Business Overview
10.6.5 Silver-Elephant Recent Developments
10.7 Lanzhou Weiri
10.7.1 Lanzhou Weiri Natamycin Basic Information
10.7.2 Lanzhou Weiri Natamycin Product Overview
10.7.3 Lanzhou Weiri Natamycin Product Market Performance
10.7.4 Lanzhou Weiri Business Overview
10.7.5 Lanzhou Weiri Recent Developments
10.8 Langfang Meihua
10.8.1 Langfang Meihua Natamycin Basic Information
10.8.2 Langfang Meihua Natamycin Product Overview
10.8.3 Langfang Meihua Natamycin Product Market Performance
10.8.4 Langfang Meihua Business Overview
10.8.5 Langfang Meihua Recent Developments
10.9 Zhengzhou New Frey
10.9.1 Zhengzhou New Frey Natamycin Basic Information
10.9.2 Zhengzhou New Frey Natamycin Product Overview
10.9.3 Zhengzhou New Frey Natamycin Product Market Performance
10.9.4 Zhengzhou New Frey Business Overview
10.9.5 Zhengzhou New Frey Recent Developments
10.10 Chihon
10.10.1 Chihon Natamycin Basic Information
10.10.2 Chihon Natamycin Product Overview
10.10.3 Chihon Natamycin Product Market Performance
10.10.4 Chihon Business Overview
10.10.5 Chihon Recent Developments
10.11 Jiaozuo Joincare
10.11.1 Jiaozuo Joincare Natamycin Basic Information
10.11.2 Jiaozuo Joincare Natamycin Product Overview
10.11.3 Jiaozuo Joincare Natamycin Product Market Performance
10.11.4 Jiaozuo Joincare Business Overview
10.11.5 Jiaozuo Joincare Recent Developments
10.12 Beijing Oriental Rada
10.12.1 Beijing Oriental Rada Natamycin Basic Information
10.12.2 Beijing Oriental Rada Natamycin Product Overview
10.12.3 Beijing Oriental Rada Natamycin Product Market Performance
10.12.4 Beijing Oriental Rada Business Overview
10.12.5 Beijing Oriental Rada Recent Developments
10.13 Pucheng Lifecome
10.13.1 Pucheng Lifecome Natamycin Basic Information
10.13.2 Pucheng Lifecome Natamycin Product Overview
10.13.3 Pucheng Lifecome Natamycin Product Market Performance
10.13.4 Pucheng Lifecome Business Overview
10.13.5 Pucheng Lifecome Recent Developments
11 Natamycin Market Forecast by Region
11.1 Global Natamycin Market Size Forecast
11.2 Global Natamycin Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Natamycin Market Size Forecast by Country
11.2.3 Asia Pacific Natamycin Market Size Forecast by Region
11.2.4 South America Natamycin Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Natamycin by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Natamycin Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Natamycin by Type (2025-2032)
12.1.2 Global Natamycin Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Natamycin by Type (2025-2032)
12.2 Global Natamycin Market Forecast by Application (2025-2032)
12.2.1 Global Natamycin Sales (K MT) Forecast by Application
12.2.2 Global Natamycin Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Natamycin Market Size Comparison by Region (M USD)
Table 5. Global Natamycin Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Natamycin Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Natamycin Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Natamycin Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natamycin as of 2022)
Table 10. Global Market Natamycin Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Natamycin Sales Sites and Area Served
Table 12. Manufacturers Natamycin Product Type
Table 13. Global Natamycin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Natamycin
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Natamycin Market Challenges
Table 22. Global Natamycin Sales by Type (K MT)
Table 23. Global Natamycin Market Size by Type (M USD)
Table 24. Global Natamycin Sales (K MT) by Type (2019-2025)
Table 25. Global Natamycin Sales Market Share by Type (2019-2025)
Table 26. Global Natamycin Market Size (M USD) by Type (2019-2025)
Table 27. Global Natamycin Market Size Share by Type (2019-2025)
Table 28. Global Natamycin Price (USD/MT) by Type (2019-2025)
Table 29. Global Natamycin Sales (K MT) by Application
Table 30. Global Natamycin Market Size by Application
Table 31. Global Natamycin Sales by Application (2019-2025) & (K MT)
Table 32. Global Natamycin Sales Market Share by Application (2019-2025)
Table 33. Global Natamycin Sales by Application (2019-2025) & (M USD)
Table 34. Global Natamycin Market Share by Application (2019-2025)
Table 35. Global Natamycin Sales Growth Rate by Application (2019-2025)
Table 36. Global Natamycin Sales by Region (2019-2025) & (K MT)
Table 37. Global Natamycin Sales Market Share by Region (2019-2025)
Table 38. North America Natamycin Sales by Country (2019-2025) & (K MT)
Table 39. Europe Natamycin Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Natamycin Sales by Region (2019-2025) & (K MT)
Table 41. South America Natamycin Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Natamycin Sales by Region (2019-2025) & (K MT)
Table 43. Global Natamycin Production (K MT) by Region (2019-2025)
Table 44. Global Natamycin Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Natamycin Revenue Market Share by Region (2019-2025)
Table 46. Global Natamycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Natamycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Natamycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Natamycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Natamycin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Danisco Natamycin Basic Information
Table 52. Danisco Natamycin Product Overview
Table 53. Danisco Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Danisco Business Overview
Table 55. Danisco Natamycin SWOT Analysis
Table 56. Danisco Recent Developments
Table 57. DSM Natamycin Basic Information
Table 58. DSM Natamycin Product Overview
Table 59. DSM Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. DSM Business Overview
Table 61. DSM Natamycin SWOT Analysis
Table 62. DSM Recent Developments
Table 63. VGP Natamycin Basic Information
Table 64. VGP Natamycin Product Overview
Table 65. VGP Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. VGP Natamycin SWOT Analysis
Table 67. VGP Business Overview
Table 68. VGP Recent Developments
Table 69. Handary Natamycin Basic Information
Table 70. Handary Natamycin Product Overview
Table 71. Handary Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Handary Business Overview
Table 73. Handary Recent Developments
Table 74. AMTECH BIOTECH Natamycin Basic Information
Table 75. AMTECH BIOTECH Natamycin Product Overview
Table 76. AMTECH BIOTECH Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. AMTECH BIOTECH Business Overview
Table 78. AMTECH BIOTECH Recent Developments
Table 79. Silver-Elephant Natamycin Basic Information
Table 80. Silver-Elephant Natamycin Product Overview
Table 81. Silver-Elephant Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Silver-Elephant Business Overview
Table 83. Silver-Elephant Recent Developments
Table 84. Lanzhou Weiri Natamycin Basic Information
Table 85. Lanzhou Weiri Natamycin Product Overview
Table 86. Lanzhou Weiri Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Lanzhou Weiri Business Overview
Table 88. Lanzhou Weiri Recent Developments
Table 89. Langfang Meihua Natamycin Basic Information
Table 90. Langfang Meihua Natamycin Product Overview
Table 91. Langfang Meihua Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Langfang Meihua Business Overview
Table 93. Langfang Meihua Recent Developments
Table 94. Zhengzhou New Frey Natamycin Basic Information
Table 95. Zhengzhou New Frey Natamycin Product Overview
Table 96. Zhengzhou New Frey Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Zhengzhou New Frey Business Overview
Table 98. Zhengzhou New Frey Recent Developments
Table 99. Chihon Natamycin Basic Information
Table 100. Chihon Natamycin Product Overview
Table 101. Chihon Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Chihon Business Overview
Table 103. Chihon Recent Developments
Table 104. Jiaozuo Joincare Natamycin Basic Information
Table 105. Jiaozuo Joincare Natamycin Product Overview
Table 106. Jiaozuo Joincare Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Jiaozuo Joincare Business Overview
Table 108. Jiaozuo Joincare Recent Developments
Table 109. Beijing Oriental Rada Natamycin Basic Information
Table 110. Beijing Oriental Rada Natamycin Product Overview
Table 111. Beijing Oriental Rada Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Beijing Oriental Rada Business Overview
Table 113. Beijing Oriental Rada Recent Developments
Table 114. Pucheng Lifecome Natamycin Basic Information
Table 115. Pucheng Lifecome Natamycin Product Overview
Table 116. Pucheng Lifecome Natamycin Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Pucheng Lifecome Business Overview
Table 118. Pucheng Lifecome Recent Developments
Table 119. Global Natamycin Sales Forecast by Region (2025-2032) & (K MT)
Table 120. Global Natamycin Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Natamycin Sales Forecast by Country (2025-2032) & (K MT)
Table 122. North America Natamycin Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Natamycin Sales Forecast by Country (2025-2032) & (K MT)
Table 124. Europe Natamycin Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Natamycin Sales Forecast by Region (2025-2032) & (K MT)
Table 126. Asia Pacific Natamycin Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Natamycin Sales Forecast by Country (2025-2032) & (K MT)
Table 128. South America Natamycin Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Natamycin Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Natamycin Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Natamycin Sales Forecast by Type (2025-2032) & (K MT)
Table 132. Global Natamycin Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Natamycin Price Forecast by Type (2025-2032) & (USD/MT)
Table 134. Global Natamycin Sales (K MT) Forecast by Application (2025-2032)
Table 135. Global Natamycin Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Natamycin
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Natamycin Market Size (M USD), 2019-2032
Figure 5. Global Natamycin Market Size (M USD) (2019-2032)
Figure 6. Global Natamycin Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Natamycin Market Size by Country (M USD)
Figure 11. Natamycin Sales Share by Manufacturers in 2023
Figure 12. Global Natamycin Revenue Share by Manufacturers in 2023
Figure 13. Natamycin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Natamycin Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Natamycin Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Natamycin Market Share by Type
Figure 18. Sales Market Share of Natamycin by Type (2019-2025)
Figure 19. Sales Market Share of Natamycin by Type in 2023
Figure 20. Market Size Share of Natamycin by Type (2019-2025)
Figure 21. Market Size Market Share of Natamycin by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Natamycin Market Share by Application
Figure 24. Global Natamycin Sales Market Share by Application (2019-2025)
Figure 25. Global Natamycin Sales Market Share by Application in 2023
Figure 26. Global Natamycin Market Share by Application (2019-2025)
Figure 27. Global Natamycin Market Share by Application in 2023
Figure 28. Global Natamycin Sales Growth Rate by Application (2019-2025)
Figure 29. Global Natamycin Sales Market Share by Region (2019-2025)
Figure 30. North America Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Natamycin Sales Market Share by Country in 2023
Figure 32. U.S. Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Natamycin Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Natamycin Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Natamycin Sales Market Share by Country in 2023
Figure 37. Germany Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Natamycin Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Natamycin Sales Market Share by Region in 2023
Figure 44. China Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Natamycin Sales and Growth Rate (K MT)
Figure 50. South America Natamycin Sales Market Share by Country in 2023
Figure 51. Brazil Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Natamycin Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Natamycin Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Natamycin Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Natamycin Production Market Share by Region (2019-2025)
Figure 62. North America Natamycin Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Natamycin Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Natamycin Production (K MT) Growth Rate (2019-2025)
Figure 65. China Natamycin Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Natamycin Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Natamycin Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Natamycin Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Natamycin Market Share Forecast by Type (2025-2032)
Figure 70. Global Natamycin Sales Forecast by Application (2025-2032)
Figure 71. Global Natamycin Market Share Forecast by Application (2025-2032)
